Access to Affordable Medication Delayed Is Health Care Denied: State Judiciary Committee Introduces CREATES Act
22 July 2016
Partners James Matthews, David Rosen and Katy Koski, along with Senior Counsel Jason Drori, contributed an article to Bloomberg BNA’s Pharmaceutical Law & Industry Report, “Access to Affordable Medication Delayed Is Health Care Denied: State Judiciary Committee Introduces CREATES Act,” on July 22, 2016. The article discussed the bill proposed by the Senate Judiciary Committee entitled the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2016, designed to focus on drug affordability and price transparency. The authors detailed regulatory background, along with reactions and implications of CREATES.
Author(s)
Related Insights
25 April 2024
Health Care Law Today
New Favorable OIG Advisory Opinion Allows Patient Assistant Programs Funded by Drug Manufacturers
The Office of Inspector General recently issued a new favorable advisory opinion regarding patient assistance programs for 12 specific disease funds.
09 May 2024
Events
The FTC Noncompete Rule: Where Do We Go From Here?
On Tuesday, April 23, 2024, the Federal Trade Commission (FTC) voted to finalize a rule abolishing the vast majority of employee noncompetes across the United States.
24 April 2024
Article
FTC Finalizes Rule Against Employee Noncompetes
On April 23, 2024, the Federal Trade Commission voted to finalize a rule abolishing the vast majority of employee noncompetes across the United States.